Class information for:
Level 1: FUSED TOES HOMOLOG//PAN RAS//A RADIATION DOSE OF 27 GY

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
24042 325 37.6 86%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
112 3       CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY 70812
32 2             HUMAN PAPILLOMAVIRUS//HPV//CERVICAL CANCER 32910
24042 1                   FUSED TOES HOMOLOG//PAN RAS//A RADIATION DOSE OF 27 GY 325

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 FUSED TOES HOMOLOG authKW 211396 1% 75% 3
2 PAN RAS authKW 169115 1% 60% 3
3 A RADIATION DOSE OF 27 GY authKW 93954 0% 100% 1
4 ABERRANT IMMUNOREACTIVITY authKW 93954 0% 100% 1
5 ADOPTIVE NK IMMUNOTHERAPY authKW 93954 0% 100% 1
6 ADVANCED CANCER OF THE CERVIX authKW 93954 0% 100% 1
7 AUMS MED address 93954 0% 100% 1
8 BCL 2 ESPRESSION authKW 93954 0% 100% 1
9 BIOL SCI ENGN CANC MINIST EDUC address 93954 0% 100% 1
10 BIOLOGICAL PROGNOSTIC FACTOR authKW 93954 0% 100% 1

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Oncology 5623 67% 0% 218
2 Obstetrics & Gynecology 2987 29% 0% 95
3 Pathology 509 12% 0% 38
4 Radiology, Nuclear Medicine & Medical Imaging 29 5% 0% 16
5 Reproductive Biology 27 2% 0% 7
6 Medicine, Research & Experimental 18 4% 0% 13
7 Medical Laboratory Technology 11 1% 0% 4
8 Cell Biology 4 4% 0% 13
9 Anatomy & Morphology 3 1% 0% 2
10 Biotechnology & Applied Microbiology 1 2% 0% 8

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 AUMS MED 93954 0% 100% 1
2 BIOL SCI ENGN CANC MINIST EDUC 93954 0% 100% 1
3 GRP ONCOL GINECOL 93954 0% 100% 1
4 HEPATOBILIA 93954 0% 100% 1
5 HISTOCHEM ELE ON MICROSCOPY 93954 0% 100% 1
6 IAC TASK FORCE 5 93954 0% 100% 1
7 IFR PHYSIOL PATHOPHYSIOL 2 93954 0% 100% 1
8 JOHN VANE SCI GYNAECOL ONCOL 93954 0% 100% 1
9 LU683 93954 0% 100% 1
10 LUDWIG BOLTZMANN CLIN EPXT ONCOL 93954 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 GYNECOLOGIC ONCOLOGY 11944 12% 0% 38
2 EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 4617 4% 0% 12
3 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 4125 4% 0% 14
4 INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 2916 2% 0% 8
5 CANCER DETECTION AND PREVENTION 1477 2% 0% 5
6 CANCER 854 5% 0% 16
7 INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 767 4% 0% 12
8 ANTICANCER RESEARCH 692 4% 0% 12
9 JOURNAL OF CLINICAL PATHOLOGY 681 2% 0% 8
10 AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 501 1% 0% 4

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 FUSED TOES HOMOLOG 211396 1% 75% 3 Search FUSED+TOES+HOMOLOG Search FUSED+TOES+HOMOLOG
2 PAN RAS 169115 1% 60% 3 Search PAN+RAS Search PAN+RAS
3 A RADIATION DOSE OF 27 GY 93954 0% 100% 1 Search A+RADIATION+DOSE+OF+27+GY Search A+RADIATION+DOSE+OF+27+GY
4 ABERRANT IMMUNOREACTIVITY 93954 0% 100% 1 Search ABERRANT+IMMUNOREACTIVITY Search ABERRANT+IMMUNOREACTIVITY
5 ADOPTIVE NK IMMUNOTHERAPY 93954 0% 100% 1 Search ADOPTIVE+NK+IMMUNOTHERAPY Search ADOPTIVE+NK+IMMUNOTHERAPY
6 ADVANCED CANCER OF THE CERVIX 93954 0% 100% 1 Search ADVANCED+CANCER+OF+THE+CERVIX Search ADVANCED+CANCER+OF+THE+CERVIX
7 BCL 2 ESPRESSION 93954 0% 100% 1 Search BCL+2+ESPRESSION Search BCL+2+ESPRESSION
8 BIOLOGICAL PROGNOSTIC FACTOR 93954 0% 100% 1 Search BIOLOGICAL+PROGNOSTIC+FACTOR Search BIOLOGICAL+PROGNOSTIC+FACTOR
9 C ERB B 2 HER2 93954 0% 100% 1 Search C+ERB+B+2+HER2 Search C+ERB+B+2+HER2
10 C ERB B2 STATUS 93954 0% 100% 1 Search C+ERB+B2+STATUS Search C+ERB+B2+STATUS

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 SOONTHORNTHUM, T , ARIAS-PULIDO, H , JOSTE, N , LOMO, L , MULLER, C , RUTLEDGE, T , VERSCHRAEGEN, C , (2011) EPIDERMAL GROWTH FACTOR RECEPTOR AS A BIOMARKER FOR CERVICAL CANCER.ANNALS OF ONCOLOGY. VOL. 22. ISSUE 10. P. 2166 -2178 39 41% 42
2 TIAN, WJ , HUANG, ML , QIN, QF , CHEN, Q , FANG, K , WANG, PL , (2016) PROGNOSTIC IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR OVEREXPRESSION IN PATIENTS WITH CERVICAL CANCER: A META-ANALYSIS.PLOS ONE. VOL. 11. ISSUE 7. P. - 27 57% 0
3 VOSMIK, M , LACO, J , SIRAK, I , BERANEK, M , HOVORKOVA, E , VOSMIKOVA, H , DRASTIKOVA, M , HODEK, M , ZOUL, Z , ODRAZKA, K , ET AL (2014) PROGNOSTIC SIGNIFICANCE OF HUMAN PAPILLOMAVIRUS (HPV) STATUS AND EXPRESSION OF SELECTED MARKERS (HER2/NEU, EGFR, VEGF, CD34, P63, P53 AND KI67/MIB-1) ON OUTCOME AFTER (CHEMO-) RADIOTHERAPY IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF UTERINE CERVIX.PATHOLOGY & ONCOLOGY RESEARCH. VOL. 20. ISSUE 1. P. 131-137 16 62% 4
4 YAMASHITA, H , MURAKAMI, N , ASARI, T , OKUMA, K , OHTOMO, K , NAKAGAWA, K , (2009) CORRELATION AMONG SIX BIOLOGIC FACTORS (P53, P21(WAF1), MIB-1, EGFR, HER2, AND BCL-2) AND CLINICAL OUTCOMES AFTER CURATIVE CHEMORADIATION THERAPY IN SQUAMOUS CELL CERVICAL CANCER.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 74. ISSUE 4. P. 1165-1172 20 49% 18
5 LU, X , FEKI, A , (2006) PHENOTYPIC FEATURES WITH P53 ALTERATIONS RELATED TO HUMAN PAPILLOMAVIRUS AND PROGNOSTIC EVALUATION IN CERVICAL CANCER.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 16. ISSUE 2. P. 708 -717 30 35% 8
6 CALIFANO, D , LOSITO, S , PISANO, C , SANTELLI, G , GREGGI, S , IODICE, F , DIVAGNO, G , SILVESTRO, G , TAMBARO, R , FORMATO, R , ET AL (2006) SIGNIFICANCE OF ERB-B2 IMMUNOREACTIVITY IN CERVICAL CANCER.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 11. ISSUE . P. 2071-2076 15 68% 2
7 PEREZ-REGADERA, J , SANCHEZ-MUNOZ, A , DE-LA-CRUZ, J , BALLESTIN, C , LORA, D , GARCIA-MARTIN, R , MENDIOLA, C , ALONSO, L , ALBA, E , LANZOS, E , (2009) NEGATIVE PROGNOSTIC IMPACT OF THE COEXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND C-ERBB-2 IN LOCALLY ADVANCED CERVICAL CANCER.ONCOLOGY. VOL. 76. ISSUE 2. P. 133-141 19 44% 15
8 BARBU, I , CRAITOIU, S , SIMIONESCU, CE , DRAGNEI, AM , MARGARITESCU, C , (2013) CD105 MICROVESSELS DENSITY, VEGF, EGFR-1 AND C-ERBB-2 AND THEIR PROGNOSTIC CORRELATION IN DIFFERENT SUBTYPES OF CERVICAL ADENOCARCINOMA.ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY. VOL. 54. ISSUE 3. P. 519-530 26 28% 6
9 CONESA-ZAMORA, P , TORRES-MORENO, D , ISAAC, MA , PEREZ-GUILLERMO, M , (2013) GENE AMPLIFICATION AND IMMUNOHISTOCHEMICAL EXPRESSION OF ERBB2 AND EGFR IN CERVICAL CARCINOGENESIS. CORRELATION WITH CELL-CYCLE MARKERS AND HPV PRESENCE.EXPERIMENTAL AND MOLECULAR PATHOLOGY. VOL. 95. ISSUE 2. P. 151 -155 14 52% 6
10 OZALP, SS , YALCIN, OT , TANIR, HM , DUNDAR, E , YILDIRIM, S , (2002) BCL-2 EXPRESSION IN PREINVASIVE AND INVASIVE CERVICAL LESIONS.EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY. VOL. 23. ISSUE 5. P. 419-422 11 85% 8

Classes with closest relation at Level 1



Rank Class id link
1 16041 P16INK4A//PROEX C//CERVICAL INTRAEPITHELIAL NEOPLASIA
2 23777 WIG 1//PAG608//CHROMOSOME 3Q26
3 27700 JOINT SERV BIOMARKER EVALUAT ONCOL//KI67 SCORE//LOCDIR
4 334 CERVICAL CANCER//RADICAL HYSTERECTOMY//GYNECOLOGIC ONCOLOGY
5 13947 P53//AREA BIOPATOL//BCL 2
6 456 E6//PAPILLOMAVIRUS//E7
7 31751 GLASSY CELL CARCINOMA//SUBJEFATURA INVEST BIOMED//UNIDAD INVEST MED BIOL REPROD
8 5180 C ERBB 2//HER 2 NEU//P185
9 16163 CERVICAL CANCERIZATION//CERVICAL NEOPLASIA RISK//LAVAGE TECHNIQUE
10 4440 NIMOTUZUMAB//CETUXIMAB//EGFR

Go to start page